NCT07265804

Brief Summary

This study evaluated the regenerative outcomes of immature permanent teeth with necrotic pulps treated using three scaffold types-blood clot, platelet-rich fibrin (PRF), and concentrated growth factor (CGF)-combined with either 5% or 17% EDTA as the final irrigant. Thirty teeth were randomly assigned to six treatment groups and followed clinically and radiographically for 12 months. Cone-beam computed tomography (CBCT) was used to assess root development parameters, including root length increase, apical diameter change, hard tissue formation, and periapical lesion volume. Clinical assessments included pain, swelling, sinus tract formation, percussion sensitivity, and pulp sensitivity testing. The study aimed to determine whether different scaffold materials and EDTA concentrations influence regenerative healing responses in immature necrotic teeth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

November 24, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
Last Updated

December 12, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

November 24, 2025

Last Update Submit

December 5, 2025

Conditions

Keywords

Regenerative EndodonticsPlatelet-Rich FibrinConcentrated Growth FactorBlood Clot ScaffoldEDTA Irrigation

Outcome Measures

Primary Outcomes (1)

  • Root Length Increase

    Increase in root length measured using cone-beam computed tomography (CBCT).

    Baseline to 12 months

Secondary Outcomes (5)

  • Apical Diameter Change (Apical Closure)

    Baseline to 12 months

  • Periapical Lesion Volume Reduction

    Baseline to 12 months

  • Hard Tissue Formation Volume

    Baseline to 12 months

  • Pulp Sensitivity Response

    12 months

  • Clinical Healing

    Baseline, 6 months, and 12 months

Study Arms (6)

Blood Clot + 5% EDTA

EXPERIMENTAL

Standard regenerative endodontic treatment using final irrigation with 5% EDTA followed by induction of bleeding to form a blood clot scaffold.

Procedure: Blood Clot + 5% EDTA

Blood Clot + 17% EDTA

EXPERIMENTAL

Regenerative endodontic procedure using final irrigation with 17% EDTA and blood clot scaffold formation.

Procedure: Blood Clot + 17% EDTA

PRF + 5% EDTA

EXPERIMENTAL

Regenerative endodontic procedure using platelet-rich fibrin scaffold after final irrigation with 5% EDTA.

Procedure: PRF + 5% EDTA

PRF + 17% EDTA

EXPERIMENTAL

Regenerative endodontic procedure using platelet-rich fibrin scaffold following final irrigation with 17% EDTA.

Procedure: PRF + 17% EDTA

CGF + 5% EDTA

EXPERIMENTAL

Regenerative endodontic protocol using concentrated growth factor scaffold after final irrigation with 5% EDTA.

Procedure: CGF + 5% EDTA

CGF + 17% EDTA

EXPERIMENTAL

Regenerative endodontic procedure using concentrated growth factor scaffold following final irrigation with 17% EDTA.

Procedure: CGF + 17% EDTA

Interventions

Final irrigation with 17% EDTA followed by controlled induction of bleeding beyond the apex to produce a blood clot scaffold for regenerative endodontic treatment.

Blood Clot + 17% EDTA
PRF + 5% EDTAPROCEDURE

Application of platelet-rich fibrin (PRF) scaffold after final irrigation with 5% EDTA during regenerative endodontic therapy.

PRF + 5% EDTA

Use of platelet-rich fibrin (PRF) scaffold following final irrigation with 17% EDTA in regenerative endodontic treatment.

PRF + 17% EDTA
CGF + 5% EDTAPROCEDURE

Placement of concentrated growth factor (CGF) scaffold after final irrigation with 5% EDTA as part of the regenerative endodontic protocol.

CGF + 5% EDTA

Placement of concentrated growth factor (CGF) scaffold following final irrigation with 17% EDTA during regenerative endodontic treatment.

CGF + 17% EDTA

Final irrigation with 5% EDTA followed by induction of apical bleeding to form an intracanal blood clot scaffold as part of the regenerative endodontic procedure.

Blood Clot + 5% EDTA

Eligibility Criteria

Age9 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Immature permanent teeth with open apices
  • Diagnosis of pulp necrosis
  • Radiographic evidence of periapical pathology
  • Teeth suitable for isolation and restoration
  • Patients aged 9 to 25 years
  • No systemic diseases that contraindicate dental treatment
  • Willingness to attend follow-up visits
  • Signed informed consent by patient or guardian

You may not qualify if:

  • Teeth with root fractures
  • Teeth with severe canal curvature (\>30°)
  • Teeth with advanced root resorption
  • Periodontal pocket depth \>3 mm
  • Previous endodontic treatment or retreatment
  • Pregnancy
  • Use of antibiotics or analgesics within the last 7 days
  • Nonrestorable crowns
  • Uncooperative patients unable to attend follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kahramanmaraş Sütçü İmam University, Faculty of Dentistry

Kahramanmaraş, 46010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Dental Pulp NecrosisPeriapical Periodontitis

Interventions

Blood CoagulationEdetic AcidProlactin-Releasing Hormone

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsPeriapical DiseasesJaw DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Intervention Hierarchy (Ancestors)

HemostasisBlood Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaEthylenediaminesDiaminesPolyaminesAminesOrganic ChemicalsAcetatesAcids, AcyclicCarboxylic AcidsHypothalamic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsNeuropeptidesPeptidesAmino Acids, Peptides, and ProteinsNerve Tissue ProteinsProteins

Study Officials

  • Aliye Kamalak

    Kahramanmaraş Sütçü İmam University, Faculty of Dentistry, Department of Endodontics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No blinding was possible because the type of scaffold (blood clot, PRF, or CGF) and the EDTA concentration (5% or 17%) were visibly identifiable during the clinical procedure. Operators could not be masked, and participants were aware of the treatment steps, making the study open label.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study used a parallel-group interventional model in which 30 immature permanent teeth diagnosed with pulp necrosis were randomly assigned to six treatment arms. Each participant received only one intervention, consisting of one scaffold type (blood clot, PRF, or CGF) combined with either 5% or 17% EDTA as the final irrigant. All groups were treated and followed simultaneously, and no crossover occurred between interventions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

November 24, 2025

First Posted

December 5, 2025

Study Start

October 1, 2023

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

December 12, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD), including CBCT images and clinical records, will not be shared due to patient confidentiality and ethical restrictions stated by the institutional review board.

Locations